The Institute of Advanced Sciences (INADS) is proud to announce the official granting of a patent for its innovative research on botulinum neurotoxin. The patent, titled “Complex of Botulinum Neurotoxin and its Binding Protein as a Formulation with Enhanced Potency” (Patent No: US 11,957,740 B2), was granted by the United States Patent and Trademark Office (USPTO) on April 16, 2024. This groundbreaking invention focuses on a novel composition comprising a complex of botulinum neurotoxin E and its binding protein. The patent covers the composition and the methods for preparing the complex and its potential therapeutic and cosmetic uses.
Botulinum toxin, one of the most potent molecules known to science, has long been recognized for its ability to block nerve signals and is widely used in therapeutic and cosmetic applications. The INADS patent advances this technology by offering a new formulation that enhances the potency of botulinum neurotoxin E through its interaction with a neurotoxin-binding protein.
“We are excited to have the expansion of our innovative capabilities officially recognized with this patent,” said Professor (Dr.) Bal Ram Singh, President of INADS. “This patent represents our dedication to pushing the boundaries of what is possible not only in the field of botulinum toxin but also in the fundamental science of protein chemistry. It is a testament to the hard work and dedication of our talented team.” Dr. Raj Kumar, Associate Professor and Director at INADS, added, “Unfolding the horizon of botulinum toxin is an intriguing field for understanding the biochemistry associated with this molecule. Receiving recognition from the USPTO is incredibly encouraging. At INADS, we are not only working to understand the fundamentals of protein chemistry through this molecule, but also aiming to create future therapeutic molecules. This patent is an important step towards realizing this vision.”
The Institute of Advanced Sciences (INADS) is a leading research institution focused on pioneering studies in biochemistry, molecular biology, and therapeutic technologies. With a commitment to advancing scientific knowledge, INADS aims to develop innovative solutions that address critical challenges in healthcare, biotechnology, and other fields. You can visit the website at www.INADS.org to stay informed of future press releases.
For further information, please contact:
Dr. Bal Ram Singh
+001-508-992-2042